"WASHINGTON, March 21 — Expert advisers to the government who receive money from a drug or device maker would be barred for the first time from voting on whether to approve that company’s products under new rules announced Wednesday for the F.D.A.’s powerful advisory committees."
Finally a step in the right direction. This should be the normal way of things in the regulatory space, but is practically unique under the plutocratic regime that is BushCo.
No comments:
Post a Comment